Скачать с ютуб Hybrid Closed-Loop (HCL) Therapy for People with Type 1 Diabetes who are Pregnant - NHS England в хорошем качестве

Hybrid Closed-Loop (HCL) Therapy for People with Type 1 Diabetes who are Pregnant - NHS England

The aim of this webinar is to outline the process and pathways for providing HCL therapy in pregnancy FOCUS: 1) The NHS 5-year implementation strategy for HCL technologies 2) Maximising the benefits of HCL for women with Type 1 diabetes who are pregnant 3) Practical examples of how maternity services have put HCL onboarding protocols in place 4) Key considerations for ICS leads SPEAKERS: 1) Eleanor M. Scott (Chair) - Professor of Medicine (Diabetes and Maternal Health), University of Leeds & Leeds Teaching Hospitals Trust 2) Partha Kar - Type 1 Diabetes & Technology Lead. Consultant Diabetes, Portsmouth Hospitals University NHS Trust 3) Helen R. Murphy - Professor of Medicine, University of East Anglia (UEA), Norwich UK, Honorary Consultant Physician, Norfolk & Norwich University NHS Hospital Trust, Chair National Pregnancy in Diabetes (NPID) audit 4) Nina Willer - Diabetes Specialist Midwife, Norfolk & Norwich University NHS Hospital Trust 5) Emma Wilmot – Associate Professor, University of Nottingham School of Medicine, Honorary Consultant Diabetologist, University Hospitals of Derby and Burton. Founder, Diabetes Technology Network UK 6) Karen Kennedy - Assistant Director, National Diabetes Programme, NHS England